144 related articles for article (PubMed ID: 29522271)
1. Inhibition of PC4 radiosensitizes non-small cell lung cancer by transcriptionally suppressing XLF.
Zhang T; Liu X; Chen X; Wang J; Wang Y; Qian D; Pang Q; Wang P
Cancer Med; 2018 Apr; 7(4):1326-1337. PubMed ID: 29522271
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human positive cofactor 4 radiosensitizes human esophageal squmaous cell carcinoma cells by suppressing XLF-mediated nonhomologous end joining.
Qian D; Zhang B; Zeng XL; Le Blanc JM; Guo YH; Xue C; Jiang C; Wang HH; Zhao TS; Meng MB; Zhao LJ; Hao JH; Wang P; Xie D; Lu B; Yuan ZY
Cell Death Dis; 2014 Oct; 5(10):e1461. PubMed ID: 25321468
[TBL] [Abstract][Full Text] [Related]
3. Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer.
Peng Y; Yang J; Zhang E; Sun H; Wang Q; Wang T; Su Y; Shi C
Cancer Gene Ther; 2012 Oct; 19(10):690-6. PubMed ID: 22918472
[TBL] [Abstract][Full Text] [Related]
4. RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer.
Wang Y; Gudikote J; Giri U; Yan J; Deng W; Ye R; Jiang W; Li N; Hobbs BP; Wang J; Swisher SG; Fujimoto J; Wistuba II; Komaki R; Heymach JV; Lin SH
Clin Cancer Res; 2018 Jan; 24(2):341-350. PubMed ID: 29030353
[No Abstract] [Full Text] [Related]
5. Efficacy of a small molecule inhibitor of the transcriptional cofactor PC4 in prevention and treatment of non-small cell lung cancer.
Zhang Y; Pavlov A; Malik S; Chen H; Kim N; Li Z; Zhang X; DePamphilis ML; Roeder RG; Ge H
PLoS One; 2020; 15(3):e0230670. PubMed ID: 32231397
[TBL] [Abstract][Full Text] [Related]
6. XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
Yang S; Wang XQ
BMC Cancer; 2017 May; 17(1):344. PubMed ID: 28526069
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression.
Guo S; Yang P; Jiang X; Li X; Wang Y; Zhang X; Sun B; Zhang Y; Jia Y
Oncotarget; 2017 Jan; 8(1):644-657. PubMed ID: 27893417
[TBL] [Abstract][Full Text] [Related]
8. GSK3β overexpression indicates poor prognosis and its inhibition reduces cell proliferation and survival of non-small cell lung cancer cells.
Zeng J; Liu D; Qiu Z; Huang Y; Chen B; Wang L; Xu H; Huang N; Liu L; Li W
PLoS One; 2014; 9(3):e91231. PubMed ID: 24618715
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of G-protein-signaling modulator 2 promotes metastasis of non-small-cell lung cancer by inducing the expression of Snail.
Deng M; Liu B; Zhang Z; Chen Y; Wang Y; Wang X; Lv Q; Yang X; Hou K; Che X; Qu X; Liu Y; Zhang Y; Hu X
Cancer Sci; 2020 Sep; 111(9):3210-3221. PubMed ID: 32519357
[TBL] [Abstract][Full Text] [Related]
10. High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer.
Chen X; Qian D; Cheng J; Guan Y; Zhang B; Ding X; Zeng J; Chen X; Er P; Zhang F; Zhao N; Chen X; Zhao L; Yuan Z; Pang Q; Wang P
Tumour Biol; 2016 Oct; 37(10):13489-13498. PubMed ID: 27465554
[TBL] [Abstract][Full Text] [Related]
11. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining.
Ahnesorg P; Smith P; Jackson SP
Cell; 2006 Jan; 124(2):301-13. PubMed ID: 16439205
[TBL] [Abstract][Full Text] [Related]
12. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression.
Sun Y; Jin SD; Zhu Q; Han L; Feng J; Lu XY; Wang W; Wang F; Guo RH
Oncotarget; 2017 Apr; 8(17):28297-28311. PubMed ID: 28423699
[TBL] [Abstract][Full Text] [Related]
15. CHAF1B promotes proliferation and reduces apoptosis in 95‑D lung cancer cells and predicts a poor prognosis in non‑small cell lung cancer.
Duan Y; Liu T; Li S; Huang M; Li X; Zhao H; Li J
Oncol Rep; 2019 Apr; 41(4):2518-2528. PubMed ID: 30720130
[TBL] [Abstract][Full Text] [Related]
16. Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype.
Zhang L; Zhang J; Ma Y; Chen J; Dong B; Zhao W; Wang X; Zheng Q; Fang F; Yang Y
Lung Cancer; 2015 Sep; 89(3):320-8. PubMed ID: 26144287
[TBL] [Abstract][Full Text] [Related]
17. SFPQ•NONO and XLF function separately and together to promote DNA double-strand break repair via canonical nonhomologous end joining.
Jaafar L; Li Z; Li S; Dynan WS
Nucleic Acids Res; 2017 Feb; 45(4):1848-1859. PubMed ID: 27924002
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Lncrna PVT1 Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Sponging Mir-195.
Wu D; Li Y; Zhang H; Hu X
Cell Physiol Biochem; 2017; 42(6):2453-2466. PubMed ID: 28848163
[TBL] [Abstract][Full Text] [Related]
19. XRCC4/XLF Interaction Is Variably Required for DNA Repair and Is Not Required for Ligase IV Stimulation.
Roy S; de Melo AJ; Xu Y; Tadi SK; Négrel A; Hendrickson E; Modesti M; Meek K
Mol Cell Biol; 2015 Sep; 35(17):3017-28. PubMed ID: 26100018
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of PC4 increases chemosensitivity of Oxaliplatin in triple negative breast cancer by suppressing mTOR pathway.
Wang Q; Ma L; Chen L; Chen H; Luo M; Yang W; Liao F; Gong Q; Wang Y; Yang Z; Wu J; Zhang C; Zheng J; Han S; Leng Y; Luo P; Shi C
Biochem Biophys Res Commun; 2021 Mar; 544():65-72. PubMed ID: 33524870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
